«I am getting better» and «I feel good»: searching for an objective criterion for a clinical response to analgesic therapy for rheumatic diseases

«I am getting better» and «I feel good»: searching for an objective criterion for a clinical response to analgesic therapy for rheumatic diseases

Analysis of the results of clinical trials should be based on the use of objective parameters that allow for assessing the significance of the data obtained for real medical practice. These parameters include Minimal Clinically Important Improvement (MCII) and Patient Acceptable Symptom State (PASS)...

Full description

Bibliographic Details
Main Authors:	A. E. Karateev, E. Yu. Pogozheva, V. N. Amirdzanova, E. S. Filatova, V. A. Nesterenko
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2020-05-01
Series:	Современная ревматология
Subjects:	остеоартрит ревматоидный артрит боль оценка минимальное клинически значимое улучшение состояние симптома, приемлемое для пациента
Online Access:	https://mrj.ima-press.net/mrj/article/view/1023

Similar Items

Rheumatic pain management: molecular aspects
by: E. V. Chetina, et al.
Published: (2020-03-01)

Analgesics in rheumatic diseases – a necessary component of therapy aimed at improving the quality of life
by: A. E. Karateev
Published: (2022-10-01)

Contribution of neurogenic mechanisms to the pathogenesis of chronic joint pain
by: E. S. Filatova, et al.
Published: (2021-04-01)

Regular use of non-steroidal anti-inflammatory drugs can effectively control pain and global health in patients with moderate activity of rheumatoid arthritis
by: A. E. Karateev, et al.
Published: (2021-04-01)

Comparison of clinical manifestations of rheumatoid arthritis in patients with moderate or high disease activity depending on the presence or absence of symptoms of neuropathic pain
by: E. Yu. Polishchuk, et al.
Published: (2021-12-01)

A very early clinical response to treatment with the Janus kinase inhibitor tofacitinib in patients with active rheumatoid arthritis: the dynamics of pain and central sensitization elements
by: A. E. Karateev, et al.
Published: (2020-05-01)

Assessing the status of patients with rheumatoid arthritis: modern tendencies
by: A. M. Lila, et al.
Published: (2020-05-01)

ETHORICOXIB IN THE TREATMENT OF RHEUMATIC DISEASES
by: Yu A Olyunin, et al.
Published: (2010-03-01)

ПРОБИОТИКИ ПРИ РЕВМАТИЧЕСКИХ ЗАБОЛЕВАНИЯХ: СИСТЕМАТИЧЕСКИЙ ОБЗОР
by: К.М. Гонсалвеш, et al.
Published: (2023-09-01)

Capabilities of ultrasonography in the diagnosis of early rheumatoid arthritis and hand osteoarthritis
by: I. A. Krivotulova, et al.
Published: (2021-04-01)

Rheumatoid arthritis: A major symptom and symptomatic therapy
by: Yuri Aleskandrovich Olyunin
Published: (2014-12-01)

PAIN IN RHEUMATOID ARTHRITIS: SPECIFIC FEATURES OF ITS DEVELOPMENT AND METHODS OF CORRECTION
by: Yuri Aleksandrovich Olyunin
Published: (2010-06-01)

ETORICOXIB IS A NEW SELECTIVE CYCLOOXYGENASE-2 INHIBITOR
by: A E Karateev
Published: (2009-06-01)

Rheumatoid arthritis in real clinical practice. Results of the «Computer Terminals of Self-Assessment for Patients with Rheumatic Diseases» («TERMINAL-I») project
by: V. N. Amirdzhanova, et al.
Published: (2019-05-01)

EU Registries Forum Meeting is a new step in the development of international cooperation in rheumatic diseases registries
by: D. E. Karateev
Published: (2015-06-01)

The influence of prolonged antithrombotic therapy on the development of post-thrombotic syndrome in patients with proximal deep vein thrombosis of the lower limbs
by: A. S. Petrikov, et al.
Published: (2018-12-01)

Efficiency of orthotic intervention in the rehabilitation of patients with rheumatoid arthritis
by: E. V. Orlova, et al.
Published: (2016-09-01)

Methotrexate in the treatment of rheumatic disease
by: Marina Zinovyevna Kanevskaya, et al.
Published: (2013-12-01)

Features of the subpopulation composition of dendritic cells in patients with rheumatoid arthritis
by: M. A. Korolev, et al.
Published: (2019-09-01)

Features of geriatric status in elderly patients with osteoarthritis combined with neuropathic pain: data from the Russian epidemiological study EVKALIPT
by: A. V. Naumov, et al.
Published: (2022-06-01)

Indicators of rheumatoid arthritis disease activity. An association with a patient’s psychological status
by: V. V. Rybakova, et al.
Published: (2020-05-01)

Chronic back pain from rheumatologist point of view
by: Yu. A. Olyunin, et al.
Published: (2022-10-01)

Ревматоидный артрит: лечение до достижения цели
by: Editorial Article
Published: (2013-12-01)

Assessment of pain in rheumatoid arthritis. Practical significance
by: Yu. A. Olyunin
Published: (2019-03-01)

Long-term use of nonsteroidal anti-inflammatory drugs for pain control in patients with osteoarthritis: results of the 12-month observational study AELITA (Analgesia: Effective Treatment Using The Therapeutic Algorithm)
by: A. E. Karateev, et al.
Published: (2021-12-01)

COMPARISON OF HEART RATE VARIABILITY ADJUSTED FOR AGE AND HEART RATE IN WOMEN WITH RHEUMATOID ARTHRITIS AND WOMEN WITHOUT RHEUMATIC DISEASES
by: D. S. Novikova, et al.
Published: (2015-09-01)

Efficiency and safety of leflunomide in rheumatoid arthritis: Results of a Russian observational multicenter of trial
by: R. M. Balabanova, et al.
Published: (2015-06-01)

New etanercept biosimilar — expanding treatment options for immune-mediated inflammatory rheumatic diseases
by: A. E. Karateev, et al.
Published: (2022-12-01)

ASSESSMENT OF THE COMPARATIVE EFFICIENCY AND LONG-TERM RESULTS OF TREATMENT OF RHEUMATIC ARTHRITIS
by: G. T. Bekenova, et al.
Published: (2016-06-01)

GOLIMUMAB — A NEW TNF α-BLOCKER. THE REVIEW OF THE EFFICACY AND SAFETY EVALUATION RESULTS
by: R. V. Denisova, et al.
Published: (2012-07-01)

Central muscle relaxants in rheumatology practice
by: E. Yu. Polishchuk, et al.
Published: (2021-12-01)

Prevalence of rheumatic diseases TOC \o "1-5" \h \z in Karelia Repablic
by: N N Vesikova, et al.
Published: (2003-04-01)

INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS?
by: R M Balabanova, et al.
Published: (2010-03-01)

SECONDARY AMYLOIDOSIS WITH LUNG INVOLVEMENT INA FEMALE PATIENT WITH RHEUMATOID ARTHRITIS
by: Irina Mikhailovna Marusenko, et al.
Published: (2009-09-01)

CYCLOSPORINE A IN RHEUMATOID ARTHRITIS: CURRENT DATA
by: Elena Lvovna Luchikhina
Published: (2009-09-01)

A new trend in pathogenetic treatment of rheumatoid arthritis: tofacitinib, the first inhibitor of Janus kinase
by: Dmitry Evgenyevich Karateev
Published: (2014-03-01)

Once more about the safety of nimesulide
by: R M Balabanova, et al.
Published: (2011-12-01)

Resolution of the consensus of the Russian Federation experts on the diagnosis and treatment of osteoarthritis, 2022
by: A. M. Lila, et al.
Published: (2022-12-01)

Rheumatoid arthritis in real clinical practice: initiation of therapy with biological agents. Results of the «Computer Terminals of Self-Assessment for Patients with Rheumatic Diseases» («TERMINAL-II») project
by: V. N. Amirdzhanova, et al.
Published: (2019-09-01)

Efficacy and safety of leflunomide in patients with rheumatoid arthritis in real-life clinical practice (results of the Russian multicenter surveillance study)
by: R.M. Balabanova, et al.
Published: (2014-05-01)